Mureidomycin A, a new inhibitor of bacterial peptidoglycan synthesis.

Mureidomycin A (MRD), a novel peptidylnucleoside antibiotic with antipseudomonal activity, inhibited not only peptidoglycan synthesis but also lipid-intermediate formation from UDP-N-acetylmuramyl (MurNAc)-pentapeptide and UDP-N-acetylglucosamine in an in vitro peptidoglycan-synthesizing system, usi...

Descrición completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Principais autores:	Isono, F, Inukai, M
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Microbiology (ASM) 1991
Assuntos:	Research Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC244983/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1902646/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.2.234
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!